Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial [Yahoo! Finance]
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers [Seeking Alpha]
Anteris Technologies Global (AVR) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $15.00 price target on the stock.
Anteris Technologies Global (AVR) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $15.00 price target on the stock.